High materiality7/10
Bicara Therapeutics price target raised to $33 from $30 at Wedbush
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush raises BCAX target to $33. Current price is $23.76. Price Change Since Signal: +2.66%.
- Wedbush raises BCAX target to $33; price $23.76.
Key facts
- 01
Target: $33
- 02
Posted price: $23.76
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.